Kura Oncology (KURA) news

Kura Oncology - Ind-enabling development underway for phase 1 proof-of-concept study of KO-7246

Kura Oncology, Inc. (NASDAQ: KURA) is currently advancing its IND-enabling development program for KO-7246, a novel investigational agent, in preparation for a phase 1 proof-of-concept study. The compound is being developed as a potential treatment for patients with specific oncologic conditions,…

Caspian Therapeutics and Kura Oncology outline Ko-7246 development strategy in diabetes

Mohamed Aiman Kamal El Din Mohamed Abdul Khaliq Korra sells 34.2 mln shares in Korra Holding for EGP 205.3 mln - EGX

Mohamed Aiman Kamal El Din Mohamed Abdul Khaliq Korra has sold 34.2 million shares in Korra Holding (KORA) for a total value of EGP 205.3 million, according to recent data from the Egyptian Exchange . The transaction reflects significant activity in the stock, which has seen a recent decline in…

Yara: Citigroup cuts target price to NOK 450 from NOK 530

Citigroup has revised its price target for Yara International ASA, reducing it to NOK 450 from the previous NOK 530, reflecting updated expectations for the company’s financial performance and market conditions. The adjustment comes amid ongoing evaluations of the fertilizer sector, where Yara…

Kemira has completed acquisition of Sidra Wasserchenie

Kemira Oyj, a leading provider of water treatment solutions, has completed the acquisition of Sidra Wasserchemie GmbH, a German-based company specializing in chemical solutions for water treatment and industrial processes. The acquisition, which was previously announced, is expected to strengthen…